Literature DB >> 12990431

Treatment of chronic leukemias; results of therapy by titrated, regularly spaced total body radioactive phosphorus, or roentgen irradiation.

E E OSGOOD, A J SEAMAN.   

Abstract

Entities:  

Keywords:  IODINE, RADIOACTIVE/therapeutic use; LEUKEMIA/therapy; RADIOTHERAPY

Mesh:

Substances:

Year:  1952        PMID: 12990431     DOI: 10.1001/jama.1952.03680140010003

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN: 0002-9955


× No keyword cloud information.
  8 in total

1.  [DURATION OF DISEASE AND SURVIVAL TIME IN MULTIPLE MYELOMA].

Authors:  P OBRECHT; E KALLITERAKIS; D KLEMM
Journal:  Klin Wochenschr       Date:  1963-09-15

2.  Hypogammaglobulinaemia in chronic lymphatic leukaemia.

Authors:  G H FAIRLEY; R B SCOTT
Journal:  Br Med J       Date:  1961-10-07

3.  Treatment of chronic granulocytic leukemia.

Authors: 
Journal:  Can Med Assoc J       Date:  1968-07-20       Impact factor: 8.262

4.  [Coincidence of plasmacytoma, chronic lymphatic leukemia, and rectal carcinoma occurring together in a family].

Authors:  H P Lohrmann; G Schneider; K Merten; A Tenbaum
Journal:  Blut       Date:  1972-06

5.  [Lymphosarcomatosis in the course of a chronic lymphatic leukemia].

Authors:  D Müller; W Langer; W Wilmanns; H V Gärtner; G Schubert
Journal:  Blut       Date:  1972-01

6.  Chronic granulocytic leukaemia: comparison of radiotherapy and busulphan therapy. Report of the Medical Research Council's working party for therapeutic trials in leukaemia.

Authors: 
Journal:  Br Med J       Date:  1968-01-27

7.  Occurrence of second neoplasms in chronic lymphocytic leukemia. Experience at Padua Hospital between 1979 and 1991.

Authors:  G Bertoldero; G Scribano; L Podda; R Berti; G Amadori
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

Review 8.  Autoimmune Hemolytic Anemia in Chronic Myeloid Leukemia.

Authors:  Tahseen Hamamyh; Mohamed A Yassin
Journal:  Pharmacology       Date:  2020-06-02       Impact factor: 2.547

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.